Cognition as a treatment target in depression

Psychological Medicine

Volumn 47, Issue 6, 2017, Pages 987-989

  Kaser, M ^a,b,c   Zaman, R ^a   Sahakian, B J ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c CAMBRIDGESHIRE AND PETERBOROUGH NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cognition; depression; neuropsychological model; treatment target

Indexed keywords

COGNITIVE DEFECT; COMPLICATION; DEPRESSION; HUMAN;

COGNITIVE DYSFUNCTION; DEPRESSIVE DISORDER; HUMANS;

EID: 85003967086     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291716003123     Document Type: Review

References (27)

1. Bora E, Harrison BJ, Yücel M, Pantelis C (2013). Cognitive impairment in euthymic major depressive disorder: a meta-analysis. Psychological Medicine 43, 2017-2026.
2. Buist-Bouwman MA, Ormel J, de Graaf R, Vollebergh WA (2004). Functioning after a major depressive episode: complete or incomplete recovery? Journal of Affective Disorders 82, 363-371.
3. Clark Health Communications (2015). Survey of British adults diagnosed with depression on behalf of Clark Health Communications (http://www.comres.co.uk/wp-content/ uploads/2015/09/Clark-Health-Communications- Cognitive-Dysfunction-in-Depression.pdf).
4. Conradi HJ, Ormel J, De Jonge P (2011). Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study. Psychological Medicine 41, 1165-1174.
5. DeBattista C, Lembke A, Solvason HB, Ghebremichael R, Poirier J (2004). A prospective trial of modafinil as an adjunctive treatment of major depression. Journal of Clinical Psychopharmacology 24, 87-90.
6. Dotson VM, Beydoun MA, Zonderman AB (2010). Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment. Neurology 75, 27-34.
7. Druss BG, Schlesinger M, Allen Jr. HM (2001). Depressive symptoms, satisfaction with health care, and 2-year work outcomes in an employed population. American Journal of Psychiatry 158, 731-734.
8. Gorwood P, Corruble E, Falissard B, Goodwin GM (2008). Toxic effects of depression on brain function: impairment of delayed recall and the cumulative length of depressive disorder in a large sample of depressed outpatients. American Journal of Psychiatry 165, 731-739.
9. Goss AJ, Kaser M, Costafreda SG, Sahakian BJ, Fu CH (2013). Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials. Journal of Clinical Psychiatry 74, 1101-1107.
10. Harmer CJ, O'Sullivan U, Favaron E, Massey-Chase R, Ayres R, Reinecke A, Goodwin GM, Cowen PJ (2009). Effect of acute antidepressant administration on negative affective bias in depressed patients. American Journal of Psychiatry 166, 1178-1184.
11. Hasselbalch BJ, Knorr U, Kessing LV (2011). Cognitive impairment in the remitted state of unipolar depressive disorder: a systematic review. Journal of Affective Disorders 134, 20-31.
12. Jaeger J, Berns S, Uzelac S, Davis-Conway S (2006). Neurocognitive deficits and disability in major depressive disorder. Psychiatry Research 145, 39-48.
13. Katona C, Hansen T, Olsen CK (2012). A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder. International Clinical Psychopharmacology 27, 215-223.
14. Keefe RS, McClintock SM, Roth RM, Doraiswamy PM, Tiger S, Madhoo M (2014). Cognitive effects of pharmacotherapy for major depressive disorder: a systematic review. Journal of Clinical Psychiatry 75, 864-876.
15. Kessing LV (1998). Cognitive impairment in the euthymic phase of affective disorder. Psychological Medicine 28, 1027-1038.
16. Kessing LV, Andersen PK (2004). Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder? Journal of Neurology, Neurosurgery and Psychiatry 75, 1662-1666.
17. Lam RW, Michalak EE, Bond DJ, Tam EM, Axler A, Yatham LN (2012). Which depressive symptoms and medication side effects are perceived by patients as interfering most with occupational functioning? Depression Research and Treatment. Article ID 630206, 6 pp, doi:10.1155/2012/630206.
18. Majer M, Ising M, Künzel H, Binder EB, Holsboer F, Modell S, Zihl J (2004). Impaired divided attention predicts delayed response and risk to relapse in subjects with depressive disorders. Psychological Medicine 34, 1453-1463.
19. McIntyre RS, Cha DS, Soczynska JK, Woldeyohannes HO, Gallaugher LA, Kudlow P, Alsuwaidan M, Baskaran A (2013). Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depression and Anxiety 30, 515-527.
20. McIntyre RS, Lophaven S, Olsen CK (2014). A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. International Journal of Neuropsychopharmacology 17, 1557-1567.
21. Mørk A, Pehrson A, Brennum LT, Nielsen SM, Zhong H, Lassen AB, Miller S, Westrich L, Boyle NJ, Sanchez C, Fischer CW (2012). Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder. Journal of Pharmacology and Experimental Therapeutics 340, 666-675.
22. National Academies of Sciences, Engineering, and Medicine (2015). Enabling Discovery, Development, and Translation Of treatments for Cognitive Dysfunction in Depression: Workshop Summary. National Academies Press:Washington, D.C.
23. Rock PL, Roiser JP, Riedel WJ, Blackwell AD (2014). Cognitive impairment in depression: a systematic review and meta-analysis. Psychological Medicine 29, 1-12.
24. Roiser JP, Elliott R, Sahakian BJ (2012). Cognitive mechanisms of treatment in depression. Neuropsychopharmacology 371, 117-136.
25. Scoriels L, Jones PB, Sahakian BJ (2013). Modafinil effects on cognition and emotion in schizophrenia and its neurochemical modulation in the brain. Neuropharmacology 64, 168-184.
26. Shilyansky C,Williams LM, Gyurak A, Harris A, Usherwood T, Etkin A (2016). Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study. Lancet Psychiatry 3, 425-435.
27. World Federation of Mental Health (2012). Depression: a global crisis (http://www.who.int/mental-health/ management/depression/who-paper-depression-wfmh- 2012.pdf?ua=1).